Society of Interventional Radiology bestows highest honors

March 02, 2015

ATLANTA--The Society of Interventional Radiology presented its highest honor, the SIR Gold Medal, to Johannes Lammer, M.D., FSIR; Anne C. Roberts, M.D., FSIR; and Harvey L. Neiman, M.D., FSIR, during its Annual Scientific Meeting in Atlanta. These awards acknowledge distinguished and extraordinary service to the society or to the discipline of interventional radiology.

"When we talk about the pioneers who have impacted minimally invasive medicine, collaborated across borders and harnessed image-guided therapies to develop breakthrough treatments, we need look no further than this year's Gold Medalists," said SIR 2014-15 President James B. Spies, M.D., MPH, FSIR, who represents the society's 5,600 doctors, scientists and allied health professionals dedicated to improving health care through interventional radiology. "These SIR Gold Medalists seize every opportunity to provide visionary leadership and to advance the specialty," said Spies, chair of the radiology department at MedStar Georgetown University Hospital and professor of radiology at Georgetown University Medical Center in Washington, D.C.

Johannes Lammer, M.D., FSIR

Lammer, professor emeritus of the Medical University Vienna, Austria, served until last year as chair of its department of cardiovascular and interventional radiology. Calling Lammer "a true global representative of radiology," Spies noted that he was receiving this honor "for the contributions that he has made not only to European interventional radiology, but to our field as a whole." His research interests include vascular interventions, including endovascular aneurysm repair (EVAR) and oncologic interventions, such as transcatheter arterial chemoembolization (TACE) and biliary interventions.

Anne C. Roberts, M.D., FSIR

A past president of SIR, Roberts is chief of vascular and interventional radiology at the University of California at San Diego (UCSD) hospital and the San Diego VA hospital. Roberts is a "tireless champion of research and patient care who always gives selflessly for the betterment of the specialty," said Spies. The first chief of radiology at UCSD Thornton Hospital, which opened in 1993, Roberts held that position until 1996, when she assumed her current role. Roberts's clinical interests include pelvic congestion syndrome, invasive placenta of the uterus and inferior vena cava filters as well as the treatment of uterine fibroids with uterine fibroid embolization and magnetic resonance-guided focused ultrasound.

Harvey L. Neiman, M.D., FSIR (awarded posthumously)

Neiman, who led the American College of Radiology (ACR) first as chair of the Board of Chancellors and then as chief executive officer, retiring in 2014 after more than 20 years, is receiving the Gold Medal posthumously. Neiman spent his early career in academic practice, making substantial contributions in the diagnosis and treatment of peripheral vascular disease. Spies called Neiman "one of the earliest in the field to recognize the need for greater leadership and research initiatives within radiology." His efforts brought the message of interventional radiology to the broader radiology and medical community, and he pioneered the application of health services research to interventional and radiology practice. The Harvey L. Neiman Health Policy Institute, established by ACR in 2012, researches the role of radiology in new health care delivery and payment models.
About the Society of Interventional Radiology

The Society of Interventional Radiology is a nonprofit, professional medical society representing more than 5,600 practicing interventional radiology physicians, scientists and clinical associates, dedicated to improving patient care through the limitless potential of image-guided therapies. SIR's members work in a variety of settings and at different professional levels--from medical students and residents to university faculty and private practice physicians.

Society of Interventional Radiology

Related Uterine Fibroids Articles from Brightsurf:

Artificial tissue used to research uterine contractions
Throughout an individual's lifetime, the uterus undergoes spontaneous contractions of the uterine wall, which can induce uterine peristalsis, a specific wavelike contraction pattern.

New targeted agent produces considerable responses in patients with uterine cancer
The DNA repair-blocking drug adavosertib shrinks tumors in nearly one-third of patients in clinical trial data to be shared at the Society for Gynecologic Oncology (SGO) Annual Meeting on Women's Cancer.

Comparing effectiveness of 2 surgical methods for uterine prolapse
Uterine prolapse happens when weakened muscles and ligaments no longer provide enough support for the uterus, which then protrudes into or out of the vagina.

Uterine artery embolization can be considered for well controlled symptomatic leiomyomas
A new study published in the April 2019 issue of the American Journal of Roentgenology (AJR) investigates the safety of uterine artery embolization (UAE) for symptomatic leiomyomas in patients with various autoimmune diseases.

TGF-beta pathway protects against uterine cancer
Two new mouse models of uterine cancer reveal that the TGF-beta signaling pathway in uterine cells protects against the disease by suppressing the overgrowth and oncogenesis of the endometrium, the membrane lining the inside of the uterus.

Elagolix reduces menstrual bleeding from most common uterine tumors
A new oral drug significantly reduced menstrual bleeding for women with the most common gynecologic tumors in the United States - benign tumors that disproportionately affect African-Americans, an international clinical trial found.

Uterine cancer survivors are more likely to have cardiovascular problems
A new study in the Journal of the National Cancer Institute indicates that survivors of uterine cancer are more likely to experience cardiovascular problems years after treatment.

New drug combo improves survival of women with rare uterine cancer
Adding the monoclonal antibody drug trastuzumab -- already used to treat certain breast cancers -- to the chemotherapy regimen of women with a rare form of uterine cancer lengthens the amount of time their tumors are kept from growing, according to Johns Hopkins Medicine researchers conducting a small phase II trial of the regimen, testing its safety and value

A new tool for improving uterine transplant surgery
Future Science Group (FSG) today announced the publication of an article in Future Science OA demonstrating the first use of multispectral imaging in gynecology, in a uterine transplant setting.

Study shows increased risk of uterine fibroids in African-American women with a common form of hair
In a study of medical records gathered on hundreds of thousands of African-American women, Johns Hopkins researchers say they have evidence that women with a common form of hair loss have an increased chance of developing uterine leiomyomas, or fibroids

Read More: Uterine Fibroids News and Uterine Fibroids Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to